Frequency of the side population, MDR (UIC2), and CD34/CD38 expression in acute myeloid leukemia blood and marrow
Patient . | SP+ (%) . | MDR+(%) . | SP+ cells in different subpopulations (%) . | ||||
---|---|---|---|---|---|---|---|
MDR+ . | CD34+CD38− . | CD34+CD38+ . | CD34−CD38+ . | CD34−CD38− . | |||
1 | 9.1 | 8.1 | 2.3 | 24 | 8.1 | 39.5 | 28.4 |
2 | 4.8 | 17.3 | 0 | 20.5 | 35.9 | 3.7 | 39.9 |
3 | 5.7 | 4.9 | 1.0 | 34.3 | 11.9 | 25.7 | 28.1 |
4 | 18.1 | 10.2 | 5.8 | 0.4 | 1.3 | 22 | 76.3 |
5 | 2.8 | 22 | 14.2 | 1.9 | 0 | 58.1 | 40 |
6 | 4.9 | 0.1 | 0 | 49.5 | 2 | 16.7 | 31.9 |
7 | 13.3 | 9.4 | 1.1 | 1.1 | 18.2 | 74.7 | 6.0 |
8 | 1.3 | 54.8 | 0.3 | 0.6 | 0.4 | 45.0 | 54.0 |
9 | 2.8 | 0 | 0 | 19.3 | 54 | 6.9 | 19.8 |
10 | 29.9 | 13 | 16.6 | 5.7 | 2.7 | 90.3 | 1.4 |
11 | 3.8 | 0 | 0 | 13.8 | 51.1 | 22.2 | 12.9 |
12 | 19.7 | 11.5 | 11.4 | 4.7 | 47.2 | 6.5 | 41.7 |
13 | 0.5 | 36.1 | 36.4 | 12.2 | 17.1 | 34.2 | 36.6 |
14 | 1.2 | 5.1 | 4.1 | 1.5 | 5.2 | 45.6 | 47.8 |
15 | 6.4 | 0 | 0 | 5.9 | 48.5 | 5.0 | 40.6 |
16 | 5.6 | ND | ND | 1.8 | 94.3 | 0 | 3.9 |
Patient . | SP+ (%) . | MDR+(%) . | SP+ cells in different subpopulations (%) . | ||||
---|---|---|---|---|---|---|---|
MDR+ . | CD34+CD38− . | CD34+CD38+ . | CD34−CD38+ . | CD34−CD38− . | |||
1 | 9.1 | 8.1 | 2.3 | 24 | 8.1 | 39.5 | 28.4 |
2 | 4.8 | 17.3 | 0 | 20.5 | 35.9 | 3.7 | 39.9 |
3 | 5.7 | 4.9 | 1.0 | 34.3 | 11.9 | 25.7 | 28.1 |
4 | 18.1 | 10.2 | 5.8 | 0.4 | 1.3 | 22 | 76.3 |
5 | 2.8 | 22 | 14.2 | 1.9 | 0 | 58.1 | 40 |
6 | 4.9 | 0.1 | 0 | 49.5 | 2 | 16.7 | 31.9 |
7 | 13.3 | 9.4 | 1.1 | 1.1 | 18.2 | 74.7 | 6.0 |
8 | 1.3 | 54.8 | 0.3 | 0.6 | 0.4 | 45.0 | 54.0 |
9 | 2.8 | 0 | 0 | 19.3 | 54 | 6.9 | 19.8 |
10 | 29.9 | 13 | 16.6 | 5.7 | 2.7 | 90.3 | 1.4 |
11 | 3.8 | 0 | 0 | 13.8 | 51.1 | 22.2 | 12.9 |
12 | 19.7 | 11.5 | 11.4 | 4.7 | 47.2 | 6.5 | 41.7 |
13 | 0.5 | 36.1 | 36.4 | 12.2 | 17.1 | 34.2 | 36.6 |
14 | 1.2 | 5.1 | 4.1 | 1.5 | 5.2 | 45.6 | 47.8 |
15 | 6.4 | 0 | 0 | 5.9 | 48.5 | 5.0 | 40.6 |
16 | 5.6 | ND | ND | 1.8 | 94.3 | 0 | 3.9 |
ND indicates not done; SP, side population; MDR, multidrug resistance-1.